TNF receptor antagonists (Cengent)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameTNF receptor antagonists (Cengent)

Drug Alias NameTNF R1 antagonists (SBI)TNF antagonists (Cengent)TNF receptor antagonists (SBI)TNF antagonists (Structural Bioinformatics)tumor necrosis factor receptor antagonists (SBI) +[7]

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTumor necrosis factor inhibitors

TargetsTumor necrosis factor

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCengent Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCengent Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsInflammation

Other Information

ATC CodeN/A